Daniela Buonvicino Selected Research

Analgesia

1/2020

Dexpramipexole blocks Nav1.8 sodium channels and provides analgesia in multiple nociceptive and neuropathic pain models.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daniela Buonvicino Research Topics

Disease

4	Disease Progression 12/2023 - 01/2018
3	Multiple Sclerosis 12/2023 - 01/2020
3	Pain (Aches) 11/2022 - 10/2018
3	Brain Injuries (Brain Injury) 06/2021 - 01/2017
3	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 06/2021 - 11/2015
3	Brain Ischemia (Cerebral Ischemia) 03/2021 - 01/2017
3	Neoplasms (Cancer) 01/2020 - 01/2018
2	Epilepsy (Aura) 03/2021 - 01/2020
2	Melanoma (Melanoma, Malignant) 01/2020 - 01/2018
2	Migraine Disorders (Migraine) 10/2018 - 01/2017
2	Stroke (Strokes) 01/2018 - 01/2017
2	Brain Infarction 01/2018 - 01/2017
1	Hypersensitivity (Allergy) 11/2022
1	Secondary Headache Disorders 11/2022
1	Chronic Pain 11/2022
1	Cluster Headache (Cluster Headaches) 01/2022
1	Demyelinating Diseases (Demyelinating Disease) 06/2021
1	Seizures (Absence Seizure) 03/2021
1	Wounds and Injuries (Trauma) 03/2021
1	Nervous System Diseases (Neurological Disorders) 03/2021
1	Hypoxia (Hypoxemia) 01/2020
1	Neuralgia (Stump Neuralgia) 01/2020
1	Allergic Conjunctivitis (Giant Papillary Conjunctivitis) 01/2019
1	Brain Hypoxia-Ischemia (Hypoxia Ischemia, Brain) 11/2018
1	Hyperalgesia 10/2018
1	Neuroblastoma 01/2018
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2018
1	Infarction (Infarctions) 01/2017
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2017
1	Mitochondrial encephalopathy 01/2017
1	Chronic Disease (Chronic Diseases) 11/2015

Drug/Important Bio-Agent (IBA)

5	DexpramipexoleIBA 06/2021 - 01/2018
3	Histone Deacetylase InhibitorsIBA 11/2022 - 01/2018
3	eletriptan (Relpax)FDA Link 11/2022 - 01/2017
3	Adenosine Triphosphate (ATP)IBA 06/2021 - 01/2018
3	EnzymesIBA 10/2018 - 01/2018
2	Sirolimus (Rapamycin)FDA Link 12/2023 - 01/2017
2	Tryptamines (Triptans)IBA 11/2022 - 01/2017
2	Proteins (Proteins, Gene)FDA Link 11/2022 - 10/2018
2	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2020 - 01/2018
1	MTOR InhibitorsIBA 12/2023
1	Everolimus FDA Link 12/2023
1	Immunosuppressive Agents (Immunosuppressants)IBA 12/2023
1	PanobinostatIBA 11/2022
1	givinostatIBA 11/2022
1	Capsaicin (Zostrix)FDA Link 11/2022
1	Verapamil (Calan)FDA LinkGeneric 01/2022
1	Prednisone (Sone)FDA LinkGeneric 01/2022
1	LithiumIBA 01/2022
1	CuprizoneIBA 06/2021
1	Kainic Acid (Kainate)IBA 03/2021
1	Ionotropic Glutamate ReceptorsIBA 03/2021
1	Glutamate Receptors (Glutamate Receptor)IBA 03/2021
1	Myelin-Oligodendrocyte GlycoproteinIBA 01/2021
1	SodiumIBA 01/2020
1	benzothiazoleIBA 01/2020
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2020
1	Oxygen (Dioxygen)IBA 01/2020
1	Sodium Channels (Sodium Channel)IBA 01/2020
1	Dexamethasone (Maxidex)FDA LinkGeneric 12/2019
1	HMGB1 Protein (HMG1)IBA 01/2019
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2018
1	Indomethacin (Indometacin)FDA LinkGeneric 10/2018
1	NeuropeptidesIBA 10/2018
1	ProstaglandinsIBA 10/2018
1	NAD (NADH)IBA 01/2018
1	Oxidoreductases (Dehydrogenase)IBA 01/2018
1	CatecholaminesIBA 01/2018
1	AntioxidantsIBA 01/2018
1	Adenine FDA LinkGeneric 01/2018
1	Uncoupling Protein 2IBA 01/2018
1	pyriminilIBA 01/2018
1	Vasoconstrictor AgentsIBA 01/2017
1	Fingolimod Hydrochloride (FTY720)FDA Link 11/2015

Therapy/Procedure

1	Analgesia 01/2020
1	Therapeutics 01/2020
1	Treatment Delay 01/2017